Affiliation: Mayo Clinic
- Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureusR Banerjee
Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Eur J Clin Microbiol Infect Dis 32:827-33. 2013..Further studies of combination β-lactam therapy may provide insight into β-lactam biology, penicillin binding protein cooperativity, and novel therapeutic strategies against MRSA...
- Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hostsRitu Banerjee
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA
Infect Control Hosp Epidemiol 34:361-9. 2013..To determine prevalence, predictors, and outcomes of infection due to Escherichia coli sequence type ST131...
- Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in CaliforniaRitu Banerjee
Division of Pediatric Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
J Clin Microbiol 48:3779-81. 2010..Use of the MB assay reduced the time to detection and treatment of MDR TB...
- A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genesRitu Banerjee
Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Antimicrob Agents Chemother 54:4900-2. 2010..CRB displayed resistance to a variety of β-lactams but was hypersusceptible to cefoxitin...